Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
130 SAR | -0.31% |
|
+4.66% | 0.00% |
05/06 | MIDEAST STOCKS-Gulf markets end mixed; Egypt slips | RE |
19/05 | Avalon Pharma Swings to Profit in Q1; Revenue Down | MT |
Business Summary
Number of employees: 543
Sales per Business
SAR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Retail
67.6
%
| - | - | 229 | 67.6 % | - |
Public
21.4
%
| - | - | 72 | 21.4 % | - |
Export
11.0
%
| - | - | 37 | 11.0 % | - |
Sales per region
SAR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Saudi Arabia
100.0
%
| 303 | 100.0 % | 338 | 100.0 % | +11.82% |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 62 | 05/23/05 | |
Hisham Attar
BRD | Director/Board Member | 43 | 13/23/13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 20,000,000 | 6,000,000 ( 30.00 %) | 0 | 30.00 % |
Company contact information
Middle East Pharmaceutical Industries Co.
Second Industrial City
14331, Riyadh
+
![address Middle East Pharmaceutical Industries Company(4016)](https://cdn.zonebourse.com/static/address/166374326.png)
Sector
Sales per Business
![Consensus](/images/consensus_flch.gif)
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 70Cr | |
+20.23% | 4.37TCr | |
+26.21% | 2.28TCr | |
+20.03% | 1.55TCr | |
+18.47% | 1.43TCr | |
+52.37% | 1.28TCr | |
-0.05% | 678.76Cr | |
-11.88% | 651.62Cr | |
+12.62% | 558.78Cr | |
-8.87% | 572.55Cr |
- Stock Market
- Equities
- 4016 Stock
- Company Middle East Pharmaceutical Industries Company